Market Insights Consumer OTC Pharmaceuticals

Eye Care - Central Africa

Central Africa

Revenue in the Eye Care market amounts to US$3.51m in 2024. The market is expected to grow annually by 2.85% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (US$1,256m in 2024).
In relation to total population figures, per person revenues of US$0.04 are generated in 2024.

Key regions: Canada, Thailand, Philippines, Worldwide, United Kingdom

Market

Region

Region comparison

Currency

Analyst Opinion

The Eye Care market in Central Africa is experiencing significant growth and development, driven by various factors such as increasing awareness about eye health, rising prevalence of eye diseases, and improving healthcare infrastructure. Customer preferences in the Eye Care market in Central Africa are shifting towards preventive measures and early detection of eye diseases.

This is evident from the growing demand for regular eye check-ups and the adoption of eye care products such as contact lenses and eyeglasses. Additionally, there is a growing preference for high-quality and branded eye care products among consumers in the region. One of the key trends in the Eye Care market in Central Africa is the increasing availability of affordable eye care services and products.

This is primarily due to the efforts of both government and non-governmental organizations to improve access to eye care services in rural and remote areas. The expansion of eye care facilities, mobile clinics, and outreach programs has played a crucial role in reaching underserved populations and addressing their eye care needs. Another trend in the market is the growing demand for advanced eye care technologies and treatments.

Central Africa is witnessing an increase in the number of eye care centers equipped with state-of-the-art diagnostic and surgical equipment. This has led to a rise in the number of complex eye surgeries being performed, such as cataract surgeries and refractive surgeries. The availability of advanced treatments has not only improved the quality of eye care services but has also attracted medical tourists from neighboring countries.

Local special circumstances in Central Africa, such as a high prevalence of eye diseases and limited access to healthcare services, have contributed to the growth of the Eye Care market. Eye diseases such as cataracts, glaucoma, and refractive errors are common in the region, and there is a need for timely diagnosis and treatment. However, the lack of trained eye care professionals and infrastructure in some areas poses challenges to the delivery of quality eye care services.

Underlying macroeconomic factors, such as population growth, urbanization, and increasing disposable income, are also driving the growth of the Eye Care market in Central Africa. As the population continues to grow and urbanize, the demand for eye care services and products is expected to increase. Additionally, rising disposable income levels are enabling more people to afford eye care treatments and products, further fueling market growth.

In conclusion, the Eye Care market in Central Africa is witnessing significant growth and development, driven by increasing awareness, changing customer preferences, and improving healthcare infrastructure. The market is characterized by a shift towards preventive measures, the adoption of advanced technologies, and the availability of affordable eye care services. However, challenges such as limited access to healthcare services and a shortage of trained professionals need to be addressed to ensure sustainable growth in the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.